Opportunity Information: Apply for RFA EB 23 005
Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional) is a National Institutes of Health (NIH) funding opportunity that supports exploratory, early-stage research focused on the ethical questions that come up when bionic and robotic technologies are created and moved into real-world use. The central idea is that ethics is not an afterthought in this field; it is built into every step of the process. Projects are expected to examine bioethical issues that can arise across the full lifecycle of these technologies, including device design decisions, laboratory and preclinical work, first-in-human and later-stage testing (if applicable), and broader implementation in clinical care or community settings. Because this is an R21 mechanism, it is generally aimed at innovative, proof-of-concept work that can generate foundational evidence, frameworks, or methods that later efforts can build on. The listing notes that clinical trials are optional, meaning applicants can propose studies that do not involve clinical trials as well as projects that may include them, as long as the work fits the ethical research focus.
The scope is deliberately broad: it covers both bionic devices (such as prosthetics, neural interfaces, sensory restoration systems, or implantable assistive technologies) and robotic devices (including rehabilitation robotics, assistive robots, or other human-interactive robotic systems). The ethical research may address questions that emerge during development and translation, such as how researchers and developers should weigh benefits and risks, how informed consent should be handled when devices are complex or rapidly evolving, how to manage uncertainty about long-term effects, and how to ensure that user perspectives and lived experience meaningfully shape design and evaluation. It also naturally includes issues tied to autonomy, agency, identity, privacy and data governance (especially where sensors or neural data are involved), accountability when systems fail or behave unpredictably, fairness and access, appropriate participant selection, and responsible communication about capabilities and limitations to avoid hype or therapeutic misconception. The emphasis is not on building the devices themselves, but on producing rigorous research that clarifies ethical challenges and proposes practical, evidence-informed approaches to address them.
The opportunity is identified as RFA-EB-23-005 and falls under a discretionary grant category, with a funding activity category of health and CFDA number 93.286. The original closing date listed is 2025-01-22, and the opportunity was created on 2023-04-28. While the provided source text does not specify an award ceiling or expected number of awards, it clearly frames the program’s purpose: to stimulate bioethics research that keeps pace with fast-moving bionic and robotic innovation and helps guide responsible translation into practice.
Eligibility is broad and includes many types of U.S.-based applicants: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities. The NOFO also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions, as well as Indian/Native American tribal governments that are not federally recognized.
For international participation, the rules are specific: non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization. However, non-domestic components of U.S. organizations are eligible, and foreign components, as defined by the NIH Grants Policy Statement, are allowed. In practice, that means a U.S. applicant can include certain foreign collaborations or project components when justified and compliant with NIH policy, but a foreign institution cannot serve as the primary applicant.
Overall, this NOFO is aimed at building the ethical evidence base and practical guidance needed to develop and translate bionic and robotic devices responsibly. It supports projects that can meaningfully influence how these technologies are designed, tested, evaluated, and implemented, with careful attention to human subjects, users, communities, and the broader societal impact of increasingly intimate human-machine systems.Apply for RFA EB 23 005
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.286.
- This funding opportunity was created on 2023-04-28.
- Applicants must submit their applications by 2025-01-22. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the focus of this funding opportunity?
This opportunity supports exploratory, early-stage research on bioethical issues that arise during the development and real-world translation of bionic and robotic devices. The emphasis is on ethics as a core part of the technology lifecycle rather than something addressed after devices are already built or deployed.
What is the official name of the opportunity?
The opportunity is titled "Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)."
What agency is offering this grant?
The funding opportunity is offered by the National Institutes of Health (NIH).
What is the funding opportunity number (RFA)?
The opportunity is identified as RFA-EB-23-005.
What grant mechanism does this use, and what does that imply?
This is an R21 mechanism, which is generally intended for innovative, exploratory, proof-of-concept research. Projects are expected to generate foundational evidence, frameworks, or methods that later research can build on.
Are clinical trials required?
No. Clinical trials are optional. Applicants may propose projects without clinical trials, or propose work that includes them, as long as the project remains focused on bioethical research related to bionic and robotic device development and translation.
What kinds of technologies fall within the scope of this program?
The scope is broad and includes both bionic devices and robotic devices. Examples mentioned include prosthetics, neural interfaces, sensory restoration systems, implantable assistive technologies, rehabilitation robotics, assistive robots, and other human-interactive robotic systems.
What parts of the technology lifecycle can a project address?
Projects are expected to examine ethical issues that can arise across the full lifecycle, including device design decisions, laboratory and preclinical work, first-in-human and later-stage testing (if applicable), and broader implementation in clinical care or community settings.
Is this grant meant to fund building or engineering the devices?
The emphasis is not on building the devices themselves. The focus is on producing rigorous ethics research that clarifies ethical challenges and proposes practical, evidence-informed approaches to address them.
What kinds of bioethical questions does NIH expect projects to study?
The description highlights a range of topics, including how developers and researchers weigh benefits and risks; how informed consent should be handled when devices are complex or rapidly evolving; how to manage uncertainty about long-term effects; and how to ensure user perspectives and lived experience meaningfully shape design and evaluation.
What human-centered ethics issues are explicitly called out?
The opportunity points to issues involving autonomy, agency, identity, and ensuring that users and communities have meaningful input into design and evaluation.
Does the scope include privacy and data governance concerns?
Yes. Privacy and data governance are included, especially in contexts where sensors or neural data may be involved.
Does the program address responsibility and accountability when systems fail?
Yes. The description notes accountability concerns, including situations where systems fail or behave unpredictably.
Are fairness and access considered within scope?
Yes. Fairness and access are explicitly included among the ethical issues that may be addressed.
Does the opportunity mention responsible communication about device capabilities?
Yes. It emphasizes responsible communication about capabilities and limitations to avoid hype or therapeutic misconception.
What is the CFDA number and general funding category?
The listing notes CFDA number 93.286 and indicates the funding activity category is health.
When was this opportunity created?
The opportunity was created on 2023-04-28.
What is the closing date listed for this opportunity?
The original closing date listed is 2025-01-22.
Does the provided information state an award ceiling or number of awards?
No. The provided source text does not specify an award ceiling or the expected number of awards.
Who is eligible to apply within the United States?
Eligibility is broad and includes many U.S.-based applicant types, including state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status, other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities.
Are particular institution types explicitly highlighted as eligible?
Yes. The NOFO explicitly highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and Indian/Native American tribal governments that are not federally recognized.
Can a foreign (non-U.S.) organization apply as the main applicant?
No. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization.
Can a U.S. applicant include foreign collaborations or components?
Yes. Non-domestic components of U.S. organizations are eligible, and foreign components (as defined by the NIH Grants Policy Statement) are allowed. In practical terms, a U.S. applicant may include certain foreign project components or collaborations when justified and compliant with NIH policy, but a foreign institution cannot serve as the primary applicant.
What is the overarching purpose of this NOFO?
The program aims to stimulate bioethics research that keeps pace with fast-moving bionic and robotic innovation and helps guide responsible translation into practice, building an ethical evidence base and practical guidance for how these technologies are designed, tested, evaluated, and implemented.
Browse more opportunities from the same category: Health
Next opportunity: 1890 Institution Teaching, Research, and Extension Capacity Building Grants Program
Previous opportunity: BJA FY 23 Upholding the Rule of Law and Preventing Wrongful Convictions Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA EB 23 005
Applicants also applied for:
Applicants who have applied for this opportunity (RFA EB 23 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed) Apply for PAR 23 175 Funding Number: PAR 23 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| APS - Strengthening Health Services, Demand, and Systems in Benin Apply for 72068023APS00001 Funding Number: 72068023APS00001 Agency: Benin USAID-Cotonou Category: Health Funding Amount: $65,000,000 |
| NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed) Apply for RFA NS 24 020 Funding Number: RFA NS 24 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 021 Funding Number: RFA RM 23 021 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 020 Funding Number: RFA RM 23 020 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| AHRQ Health Services Research Dissertation Program (R36) Apply for PA 23 196 Funding Number: PA 23 196 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional) Apply for RFA NS 24 011 Funding Number: RFA NS 24 011 Agency: National Institutes of Health Category: Health Funding Amount: $3,750,000 |
| Sex Differences in Radiation Research: Models, Underlying Pathways, Biomarkers of Injury, and Medical Countermeasure Responses (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 024 Funding Number: RFA AI 23 024 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) Apply for RFA OD 23 016 Funding Number: RFA OD 23 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed) Apply for PAR 23 143 Funding Number: PAR 23 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required) Apply for PAR 23 142 Funding Number: PAR 23 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Renewal of the Longevity Consortium (U19 Clinical Trial Not Allowed) Apply for RFA AG 24 017 Funding Number: RFA AG 24 017 Agency: National Institutes of Health Category: Health Funding Amount: $9,000,000 |
| Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) Apply for PAR 23 174 Funding Number: PAR 23 174 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) Apply for PAR 23 177 Funding Number: PAR 23 177 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| HIV Prevention and Alcohol (R01 Clinical Trials Optional) Apply for PAS 23 173 Funding Number: PAS 23 173 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Prevention and Alcohol (R34 Clinical Trials Optional) Apply for PAS 23 172 Funding Number: PAS 23 172 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PAR 23 185 Funding Number: PAR 23 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 23 186 Funding Number: PAR 23 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) Apply for PAR 23 187 Funding Number: PAR 23 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) Apply for RFA NS 24 010 Funding Number: RFA NS 24 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA EB 23 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
